Page last updated: 2024-11-05

(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid and Nearsightedness

(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid has been researched along with Nearsightedness in 2 studies

(1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid: a GABA-C receptor antagonist; structure in first source

Research Excerpts

ExcerptRelevanceReference
"Myopia (short-sightedness), usually caused by excessive elongation of the eye during development, has reached epidemic proportions worldwide."4.02Transcriptome-based insights into gene networks controlling myopia prevention. ( Ashby, R; Hardy, K; Karouta, C; Kucharski, R; Maleszka, R; Morgan, I; Thomson, K, 2021)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Karouta, C1
Kucharski, R1
Hardy, K1
Thomson, K1
Maleszka, R1
Morgan, I1
Ashby, R1
Cheng, ZY1
Wang, XP1
Schmid, KL1
Han, XG1

Other Studies

2 other studies available for (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid and Nearsightedness

ArticleYear
Transcriptome-based insights into gene networks controlling myopia prevention.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2021, Volume: 35, Issue:9

    Topics: Alternative Splicing; Animals; Atropine; Chickens; Circadian Rhythm; Early Growth Response Protein 1

2021
Inhibition of form-deprivation myopia by a GABAAOr receptor antagonist, (1,2,5,6-tetrahydropyridin-4-yl) methylphosphinic acid (TPMPA), in guinea pigs.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2014, Volume: 252, Issue:12

    Topics: Animals; Axial Length, Eye; Biometry; Disease Models, Animal; Dose-Response Relationship, Drug; GABA

2014